Hikari Power Ltd - Q3 2018 holdings

$984 Million is the total value of Hikari Power Ltd's 127 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .

 Value Shares↓ Weighting
BK NewBANK OF NEW YORK MELLON CORP$1,290,00025,300
+100.0%
0.13%
SPHS NewSOPHIRIS BIO INC$474,000170,000
+100.0%
0.05%
CBIO NewCATALYST BIOSCIENCES INC$323,00030,000
+100.0%
0.03%
CRVS NewCORVUS PHARMACEUTICALS INC$275,00032,090
+100.0%
0.03%
BRKB NewBERKSHIRE HATHAWAY INC CLASS Bcl b$214,0001,000
+100.0%
0.02%
SESN NewSESEN BIO INC$141,00065,592
+100.0%
0.01%
SBPH NewSPRING BANK PHARMACEUTICALS$137,00011,336
+100.0%
0.01%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

  • Yasumitsu Shigeta #1
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2018-10-31
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
CARDINAL HEALTH39Q3 202340.7%
WELLS FARGO & CO NEW39Q3 202317.8%
JOHNSON & JOHNSON39Q3 202324.8%
VISA INC CLASS A39Q3 20234.1%
NOVO-NORDISK A S39Q3 20234.2%
EXXON MOBIL CORPORATION39Q3 20233.9%
NESTLE SA39Q3 20233.6%
COCA COLA CO39Q3 20236.4%
INTUITIVE SURGICAL INC39Q3 20232.2%
BECTON DICKINSON & CO39Q3 20232.8%

View Hikari Power Ltd's complete holdings history.

Latest filings
TypeFiled
13F-HR2024-05-08
13F-HR2024-01-31
13F-HR2023-10-26
13F-HR2023-07-26
13F-HR2023-04-26
13F-HR2023-01-25
13F-HR2022-11-01
13F-HR/A2022-07-22
13F-HR2022-07-06
13F-HR2022-04-13

View Hikari Power Ltd's complete filings history.

Compare quarters

Export Hikari Power Ltd's holdings